MD ANDERSON CANCER CENTER dedicated the Sheikh Zayed Bin Sultan Al Nahyan Building for Personalized Cancer Care. The 12-story building, now in the second phase of construction, will house the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, the Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research, and molecular... […]
THE U.S. PREVENTATIVE SERVICES TASK FORCE published a B recommendation for low-dose aspirin use for the primary prevention of colorectal cancer and cardiovascular disease in adults aged 50 to 59 years who have a 10 percent or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least... […]
JEFFREY SOSMAN will join the Robert H. Lurie Comprehensive Cancer Center of Northwestern University as co-leader of the Translational Research in Solid Tumors Program and director of the Melanoma Program, effective May 1. He will also serve as director for faculty development at the Lurie Cancer Center.
KARIN JOOSS was named chief scientific officer of Gritstone Oncology. Jooss previously served as head of Cancer Immunotherapeutics and Immunopharmacology at Pfizer for seven years. Mojca Skoberne also joined the company as senior director of immunology. Skoberne most recently served as program lead at Genocea Biosciences, a company that identifies targets of T cell responses.... […]
LYNN MATRISIAN was named the inaugural chief research officer for the Pancreatic Cancer Action Network. Matrisian was promoted from vice president of scientific and medical affairs, where she has served since 2011. Doug Laidlaw was named vice president of scientific and medical affairs, and will be responsible for overseeing the nonprofit’s research grants, patient services... […]
MAYA MARTINEZ-DAVIS was appointed global head of the oncology franchise of Merck KGaA. She will be based in Billerica, Mass., and will report to Rehan Verjee, chief marketing and strategy officer of the healthcare business sector. Martinez-Davis was a senior executive with Pfizer for more than a decade. Prior to her tenure with Pfizer, she... […]
ED SAUTER was named director of the breast surgery program at the Hartford HealthCare Cancer Institute. He will lead the breast surgery programs at each of the institute’s five cancer centers. Sauter previously served as director of the Cancer Treatment and Prevention Center at the University of Texas Health Science Center at Tyler. Prior to... […]
ERIC DISHMAN was named director of the Precision Medicine Initiative Cohort Program at NIH. Dishman will lead NIH’s effort to build the PMI longitudinal research study of one million or more volunteers. Dishman was a member of the working group that helped develop the design for the study. He succeeds Josephine Briggs, who served as... […]
Stand Up To Cancer announced Catalyst, a program that will use funding and materials from the pharmaceutical, biotechnology, diagnostic and medical devices industries to accelerate research on cancer prevention, detection and treatment.
Over the past several weeks, The Cancer Letter has been running a series of articles that report on a past conflict between people at The University of Texas MD Anderson Cancer Center and Nobel Laureate Al Gilman, who led the scientific review teams of the then newly formed Cancer Prevention and Research Institute of Texas.
